DrStockPick.com Stock Report!
Thursday September 3, 2009
Solomon Technologies, Inc. (Pink Sheets: SOLM) announced today that its Technipower subsidiary shipped several orders for power systems to a premier nuclear power plant supplier. The systems are rigorously tested, inspected and certified by the customer for use in a nuclear power generating facility’s reactor control and safety systems.
Elephant Talk Communications, Inc. (OTC Bulletin Board: ETAK), an international telecom and multimedia content distributor specializing in carrier grade mobile enabling platforms, today announced that the Company will participate in the Rodman & Renshaw Annual Global Investment Conference to be held at the New York Palace Hotel from Wednesday, September 9 to Friday, September 11, 2009.
International Rectifier (NYSE:IRF), a world leader in power management technology, today introduced the AUIRS2016S for automotive gate drive applications including common injection rails, diesel and gasoline direct injection applications and solenoid drivers. The AUIRS2016S is a high-voltage power MOSFET high-side driver featuring an internal Vs-to-GND recharge NMOS. The device’s output driver features a 250mA high pulse current buffer stage. The channel can be used to drive an N-channel power MOSFET in the high-side configuration, operating up to 150V above ground. The AUIRS2016S also provides negative voltage spike immunity (-Vs) to protect against catastrophic events during high-current switching and short circuit conditions.
The Shaw Group Inc. (NYSE: SHAW) today announced it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for the Department of Defense’s Environmental Restoration Program. Under the terms of the contract, Shaw will serve as the U.S. Army’s program manager for environmental cleanup at the Redstone Arsenal (RSA) installation in Huntsville, Ala.
XenaCare Holdings, Inc. (OTCBB: XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that it will begin its national print advertising campaign for Cobroxin in November. The campaign, which is budgeted at approximately $550,000, is scheduled to run through December and will appear in Arthritis Today, Prevention, Health, Star, Woman’s World, Soap Opera, and Self magazines.
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced definitive agreements to sell its Sleep Diagnostics and Oxygen Therapy product lines and a proposal to sell its Sleep Therapy product line. The decision to divest these three product lines was made following a thorough review and evaluation of a number of strategic alternatives. The decision is consistent with Covidien’s strategy to streamline its portfolio and reallocate resources to its faster-growing, higher-margin businesses, where the Company has or can develop a global competitive advantage.
No comments :
Post a Comment